Related Experiment Video

Updated: Oct 23, 2026

Analysis of Cell Cycle Position in Mammalian Cells
12:19

Analysis of Cell Cycle Position in Mammalian Cells

Published on: January 21, 2012

Cyclic AMP induces inhibition of cyclin A expression and growth arrest in human hepatoma cells

J Lee1, Y H Choi, P Nguyen

  • 1Medicine Branch, Division of Clinical Sciences, National Cancer Institute, National Institutes of Health, Building 10, Room 12N230, Bethesda, MD 20892, USA.

Biochimica Et Biophysica Acta
|April 21, 1999
PubMed

Insights

Cyclic AMP (cAMP) halts hepatoma cell growth and triggers apoptosis by downregulating cyclin A. This discovery offers a new signal transduction-based therapy for hepatocellular carcinoma.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Hepatocellular carcinoma (HCC) treatment remains challenging with conventional cytotoxic therapies.
  • Signal transduction pathways are critical regulators of human hepatoma cell growth.
  • Cyclic AMP (cAMP) is a known negative regulator of epithelial cell proliferation.

Purpose of the Study:

  • To investigate the effects of cAMP on human hepatoma cell growth.
  • To identify specific molecular targets within the G1/S transition pathway affected by cAMP.
  • To explore a novel signal transduction-based therapeutic approach for HCC.

Main Methods:

  • Treatment of HepG2 human hepatoma cells with cAMP analogs (8-bromo cAMP, dibutyryl cAMP).
  • Analysis of key cell cycle regulators including D-type cyclins, cyclin E, cyclin-dependent kinases (CDKs), p53, and CDK inhibitors (p21, p27).
  • Assessment of cyclin A protein, messenger RNA levels, and associated kinase activity.

Main Results:

  • cAMP induced G1 cell cycle synchronization and apoptosis in HepG2 cells.
  • No significant changes were observed in D-type cyclins, cyclin E, CDK2, CDK4, p53, p21, or p27.
  • A dramatic downregulation of cyclin A protein, mRNA, and kinase activity was observed.

Conclusions:

  • cAMP effectively inhibits hepatoma cell proliferation and induces apoptosis.
  • The mechanism involves the specific downregulation of cyclin A, a key regulator of the G1-S transition.
  • Targeting cyclin A via cAMP signaling presents a promising novel therapeutic strategy for hepatocellular carcinoma.

More Related Videos

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols12:02

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols

Published on: June 6, 2017

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
Molecular Factors Affecting Cell Division01:27

Molecular Factors Affecting Cell Division

Several external and internal factors influence the initiation and inhibition of cell division. For instance, the death of nearby cells or the release of human growth hormone (hGH) promotes cell division. In contrast, lack of hGH or crowding of cells can inhibit cell division.
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.